How Pfizer’s CEO says he uses AI to make decisions

Pfizer CEO Albert Bourla and Accenture CEO Julie Sweet discuss how they’re using AI to transform their work. Watch the full episode of The 1 on 1 with CNN at CNN.com/the1on1.

Pfizer CEO says he uses AI for his company’s biggest decisions — here are the ways AI could be involved in your portfolio without you even realizing

Maybe you’ve bought shares of AI company stocks or invested in ETFs focused on AI, technology, or computer science. Or, depending on your preferences, you might stay away from AI investments for fear ...
Yahoo Finance

Pfizer Taps Chai Discovery AI To Expand Biologics Pipeline Potential

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Pfizer's CEO uses AI to make his biggest calls — and 64% of CEOs agree, quietly shifting your portfolio

Maybe you’ve bought shares of AI company stocks or invested in ETFs focused on AI, technology, or computer science. Or, depending on your preferences, you might stay away from AI investments for fear ...
TechRepublic

Boltz Bags $28M Funding and Pfizer Partnership for Biomolecular AI Boost

The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation models. Pfizer and Boltz have announced a collaboration aimed at expanding the ...
Hosted on MSN

Pfizer collaborating with Boltz to use AI models for drug discovery

Pfizer (PFE) has entered into an agreement with Boltz to use the latter's biomolecular AI foundation models to tap into the former's historical data "to create state-of-the-art, exclusive models for ...